# Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension

> **NCT04484675** · PHASE4 · RECRUITING · sponsor: **Zagazig University** · enrollment: 38 (estimated)

## Conditions studied

- Pulmonary Hypertension Due to Left Heart Disease

## Interventions

- **DRUG:** Milrinone inhalation
- **DRUG:** Milrinone infusion

## Key facts

- **NCT ID:** NCT04484675
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-20
- **Primary completion:** 2025-05-10
- **Final completion:** 2025-05-10
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04484675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04484675, "Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04484675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*